Omar Ishrak, the Medtronic's initial non-American CEO, targets to strengthen the medical device manufacturer's growth by focusing on emerging markets, treatment initiation, and creative business models. To market, budget constraints in mature economies, the shortage of new medical therapies coming in the year 2012, as well as the decline in growth of the core companies of Medtronic has reduced the firm's once dynamic growth close to zero.
Omar Ishrak Building Medtronic Globally Case Study Solution
To reinforce Medtronic's near-term projection, he has sustained imaginative merchandise and business model innovations geared toward conquering adoption barriers in emerging markets. Ishrak restructured his executive team as well as their duties: the heads of Medtronic's world-wide managing areas and major nations, who previously reported to the head of international, now report directly to the CEO, putting seven non-Americans on the executive committee. In another important landmark, Medtronic acquired a Chinese orthopedics company, which became its first completely integrated business unit outside the U.S. Ishrak is trying to decide whether these measures are sufficient to transform Medtronic from a multinational into a truly global company and restore its increase.
PUBLICATION DATE: March 15, 2013 PRODUCT #: 413065-HCB-ENG
This is just an excerpt. This case is about ORGANIZATIONAL DEVELOPMENT
Related Case Solutions & Analyses:
CBS and Online Video
Malaysia Airlines (B)
UBS and Climate Change–Warming Up to Global Action
Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics
Interest Rates Market Pricing and Compounding
International Use of the Myers-Briggs Type Indicator
Standard Costs and Variances
North American Financial Corporation (NAF) The MLM Project (A)
Daqi Case Report
Mekong Capital
